Karnataka government unveils draft of Biotechnology policy 4.0
WHO & Ministry of Ayush ink Traditional and Complementary Medicine 'Project Collaboration Agreement'
Karnataka aims to attract Rs 40,000 Cr investment in KHIR City
Fortis Healthcare to divest Fortis Malar Hospital, Chennai to MGM Healthcare for Rs 128 Cr
Regency Healthcare secures Rs 450 Cr investment from Norwest Venture Partners
Biocon Biologics divests two non-core branded formulations to Eris for Rs 366 Cr
Indian Immunologicals unveils Measles and Rubella vaccine for children
Sanjivani Paranteral and Hindustan Antibiotics collaborate to manufacture IV formulations and IV sets
Novo Nordisk invests Kr. 42 B+ for expansion of manufacturing facilities in Denmark
New research shows failure of current policies to eradicate TB
Roche launches automated serology hepatitis E virus tests
Illumina launches Global Health Access Initiative for acceleration of pathogen sequencing in LMICs
Science | 22 November 2023 | News
IASST fabricates 2D protein monolayer to help study diseases like Amyloidosis
Scientists from the Institute of Advanced Study in Science and Technology, Guwahati (IASST), an autonomous ins...Read more
Opinion | 01 December 2023 | Views
How does the government plan to take the Indian biotech sector to the global stage through its annual event- G...Read more
MedTech | 27 November 2023 | News
India’s first IRCAD Centre to establish surgical training in collaboration with SAIMS in Indore
IRCAD India, a mirror institute of IRCAD France (Strasbourg), was inaugurated on November 24th in collaboratio...Read more
Start-ups | 02 December 2023 | News
Bengaluru Tech Summit 2023 unveils ground-breaking solutions by healthcare & medtech startups
The Department of Electronics, IT, BT, and S & T, Government of Karnataka, unveiled many ground-breaking p...Read more
Medical Diagnostic | 24 November 2023 | News
Revvity joins India’s fight against TB by launching T-SPOT.TB for latent TB screening
Revvity, a global company that leverages innovation in diagnostics and life sciences, with a strong presence i...Read more
People | 15 November 2023 | News
Dr Arun Shukla wins Infosys Prize 2023 in Life Sciences
Infosys Science Foundation (ISF) has announced the winners of the Infosys Prize 2023 in six categories &n...Read more
Academics | 21 November 2023 | News
Cloudnine signs MoU with British Association of Physicians of Indian Origin Training Academy
Cloudnine, India’s premium birthing centre for maternal and childcare, has signed a Memorandum of U...Read more
Text blogs | 15 November 2023 | Views
Education Must for Early Detection of Breast Cancer
Breast cancer (BC) is the most diagnosed type of cancer claiming the lives of more than 0.5 million women ever...Read more
From Exponential Growth to PHARMA BOOM
The Indian pharmaceutical industry is experiencing a dynamic growth landscape, marked by strategic initiatives such as partnerships, investments, Memoranda of Understanding (MoUs), and collaborations. Despite geopolitical uncertainties like the Israel-Palestine and Russia-Ukraine conflicts lingering in 2023, the healthcare and pharma sector in India continues to gain momentum through new investments and collaborative efforts. Major global players are actively engaging in partnerships, MoUs, and collaborations to secure a substantial global market share. In 2023 alone, more than 30 partnerships, MoUs and other collaborations have been forged to boost India’s pharmaceutical growth trajectory. The Indian pharmaceutical products market is projected to hit $130 billion by the end of 2030.
For Feedback, please email us at: communications@mmactiv.com
Ashirwad Bungalow, First floor,
36/A/2, S.No. 270, Pallod Farms,
Near Bank of Baroda, Baner Road,
Pune, Maharashtra, India 411045
Mob : +91-9579069369
Email : communications@mmactiv.com
